Cystatin C and parenchymal thickness/kidney length ratio in Wilms tumor survivors

Pediatric Blood and Cancer

Volumn 54, Issue 1, 2010, Pages 41-46

  Stefanowicz, Joanna ^a   Kosiak, Mateusz ^a   Kosiak, Wojciech ^a   Korbus Kosiak, Anna ^a   Sierota, Danuta ^a   Owczuk, Radoslaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cystatin C; Nephrectomy; Parenchymal thickness; Wilms tumor survivors

Indexed keywords

CREATININE; CYSTATIN C; CST3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; INFANT; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY PARENCHYMA; KIDNEY SIZE; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; UNINEPHRECTOMY; BLOOD; KIDNEY FUNCTION TEST; KIDNEY TUMOR; MORTALITY; SURVIVAL RATE; SURVIVOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; MALE; SURVIVAL RATE; SURVIVORS; WILMS TUMOR; YOUNG ADULT;

EID: 73349111647     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22249     Document Type: Article

References (42)

1. Gupta Devendra K, Sharma S, Agarwala S, et al. Saga of Wilms' tumor: Lessons learnt from the past. J Indian Assoc Pediatr Surg 2005;10:217-228.
2. Lisauer T, Clayden G. 2001. Illustrated textbook of paediatrics, 2nd edition. London: Mosby. pp 285-296.
3. Tournade MF, Com-Nougué C, de Kraker J, et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms tumor in children older than 6 months: Results of the ninth International Society of Pediatric Oncology Wilms Tumor Trial and Study. J Clin Oncol 2001;19:488-500.
4. D'Angio GJ. Pre-or post-operative treatment for Wilms tumor? Who, what, when, where, how, why-and which. Med Pediatr Oncol 2003;41:545-549.
5. Brenner B, Mackenzie H. Nephrons mass as a risk factor for the progression of renal disease. Kidney Int 1997;52:124-127.
6. Thorner P, Arbus G, Celermajer D, et al. Focal segmental glomerulosclerosis and progressive renal failure associated with a unilateral kidney. Pediatrics 1984;73:806-810.
7. Fotino S. The solitary kidney:Amodel of chronic hyperfiltration in humans. Am J Kidney Dis 1989;13:88-98.
8. Zucchelli P, Cagnoli L, Casanova S, et al. Focal glomerulosclerosis in patients with unilateral nephrectomy. Kidney Int 1983;24:649-655.
9. Saran R, Marshall S, Madsen R, et al. Long-term follow-up of kidney donors: A longitudinal study. Nephrol Dial Transplant 1997;12:1615-1621.
10. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy forWilms tumor. Int J Radiat Oncol Biol Phys 2000;46:1239-1246.
11. Bardi E, Olah VA, Bartyik K, et al. Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer 2004;43:668-673.
12. Sleijfer DT, Smit EF, Meijer S, et al. Acute and cumulative effects of carboplatin on renal function. Br J Cancer 1989;60:116-120.
13. Goren MP, Pratt CB, Viar MJ. Tubular nephrotoxicity during long term ifosfamide and Mesna theraphy. Cancer Chemother Pharmacol 1989;25:70-72.
14. Kazama JJ, Kutsuwada K, Ataka K, et al. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 2002;92:224-226.
15. Grubb A, Lofberg H. Human gamma trace. Scand J Clin Lab Invest 1985;45:7-13.
16. Tenstad O, Roald AB, Grubb A, et al. Renal handling of radiolabelled human cystatin C in the rats. Scand J Clin Lab Invest 1996;56:409-414.
17. Herget-Rosenthal S, Pietruck F,Volbracht L, et al. Serum cystatinC a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol 2005;64:41-46.
18. John GT, Fleming JJ, Talaulikar GS, et al. Measurement of renal function in kidney donors using serum cystatin C and Bmicroglobulin. Ann Clin Biochem 2003;40:656-658.
19. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 1987;34:571-590.
20. Fischbach M, Graff V, Terzic J, et al. Impact of age on reference values for serum concentration of cystatin C in children. Pediatr Nephrol 2002;17:104-106.
21. Dinkel E, Ertel M, Dittrich M, et al. Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol 1985;15:38-43.
22. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluating, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004;114:555-576.
23. Bude RO, DiPietro MA, Platt JF, et al. Age dependency of the renal resistive index in healthy children. Radiology 1992;184:469-473.
24. Di Tullio MT, Casale F, Indolfi P, et al. Compensatory hypertrophy and progressive renal damage in children nephrectomized for Wilms tumor. Med Pediatr Oncol 1996;26:325-328.
25. Cioce F, Indolfi P, Di Tulio MT, et al. Letter to the Editor: Kidney size and function after unilateral nephrectomy forWilms tumor: A longitudinal study. Med Pediatr Oncol 2001;37:485-486.
26. SrinivasM, Agarwala S, Padhy AK, et al. Somatic growth and renal function after unilateral nephrectomy for Wilms' tumor. Pediatr Surg Int 1998;14:185-188.
27. Schell M, Cochat P, Hadj-Aissa A, et al. Renal function following unilateral nephrectomy for neuroblastoma and Wilms tumor. Pediatr Nephrol 1995;9:579-582.
28. Levitt GA, Yeomans E, Dicks Mircaux C, et al. Renal size and function after cure ofWilms tumor. Br J Cancer 1992;66:877-882.
29. de Graff SSN, van Gent H, Reitsma-Bierenes W, et al. Renal function after unilateral nephrectomy for Wilms tumor: The influence of radiation therapy. Eur J Cancer 1996;32:465-469.
30. Stroińska E, Zwolińska D, Sawicz-Birkowska K, et al. Assessment of function of the only kidney in children after nephrectomy due to Wilms tumor. Pol Merkuriusz Lek 2003;14:311-314.
31. Donckerwolcke RM, Coppes MJ. Adaptation of renal function after unilateral nephrectomy in children with renal tumors. Pediatr Nephrol 2001;16:568-574.
32. Breslow NE, Collins AJ, Ritchey ML, et al. End stage of renal disease in patients with Wilms tumor: Results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 2005;174:1972-1975.
33. Filler G, Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 2003;18:981-985.
34. Bokenkamp A, Domanetzki M, Zinck R, et al. Cystatin C-A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998;101:875-881.
35. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 2002;40:221-226.
36. Wilson BE, Davies P, Shah K, et al. Renal length and inulin clearance in the radiologically normal single kidney. Pediatr Nephrol 2003;18:1147-1151.
37. Hinchcliffe S, Sargent P, Howard C, et al. Human intra-uterine renal growth expressed in absolute number of glomeruli assessed by the Disector method and Cavalieri principle. Lab Invest 1991;64:777-784.
38. Zerin JM, Haliloglu M, Cohen MD. Growth of the solitary kidney after nephrectomy in children with unilateralWilms tumor. Pediatr Radiol 1996;26:547-552.
39. NKF K/DOQI Guidelines, Definition and classification of stages of chronic kidney disease. http://www.kideny.org/professionals/ KDOQI/guidlines-ckd/p4- class-g1.htm.
40. Tublin ME, Bude RO, Platt JF. The resistive index in renal Doppler sonography: Where dowe stand?AmJ Roentgenol 2003;180:885-892.
41. Ikee R, Kobayashi S, Hemmi N, et al. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis 2005;46:603-609.
42. Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension 2002;39:699-703.